文献速递衰弱、肌少症与跌倒老年慢病共病管理

炎症与心血管生物标志物和新发衰弱的关联:英国区域心脏研究

Associations between inflammation, cardiovascular biomarkers and incident frailty: the British Regional Heart Study.
PubMed 文献 · Age Ageing · 2021-01-01

该研究基于英国区域心脏研究,对1225名71-92岁稳健或衰弱前期男性基线检测炎症与心脏功能障碍生物标志物,3年后问卷评估衰弱。

要点

  • IL-6最高三分位与新发衰弱风险升高相关(OR 2.36, 95%CI 1.07-5.17)。
  • hs-cTnT最高三分位与新发衰弱风险升高相关(OR 2.24, 95%CI 1.03-4.90)。
  • CRP与NT-proBNP最高三分位与新发衰弱无显著关联,但受生存偏倚影响。

核心结论

  • IL-6与新发衰弱相关,支持炎症参与衰弱发病机制的观点。
  • 心肌细胞损伤(hs-cTnT)可能与衰弱风险相关。
  • CRP与衰弱的关联不能完全排除,NT-proBNP与衰弱可能呈非线性关系。

研究设计与样本

  • 英国区域心脏研究,纳入1225名71-92岁稳健或衰弱前期男性,基线检测生物标志物,3年后问卷评估衰弱。
  • 衰弱定义基于Fried表型,随访数据可获取981人。

主要发现

  • 校正年龄、衰弱前期、现患及新发心血管病、共病、多重用药和社会经济地位后,IL-6第三分位与新发衰弱风险升高相关(OR 2.36, 95%CI 1.07-5.17)。
  • hs-cTnT第三分位与新发衰弱风险升高相关(OR 2.24, 95%CI 1.03-4.90)。
  • CRP第三分位与新发衰弱无显著关联(OR 1.83, 95%CI 0.97-4.08)。
  • NT-proBNP第二分位与新发衰弱无显著关联(OR 0.48, 95%CI 0.23-1.01)。

关键数值与推荐

  • IL-6第三分位对比最低分位:OR 2.36, 95%CI 1.07-5.17。
  • hs-cTnT第三分位对比最低分位:OR 2.24, 95%CI 1.03-4.90。
  • CRP第三分位对比最低分位:OR 1.83, 95%CI 0.97-4.08。
  • NT-proBNP第二分位对比最低分位:OR 0.48, 95%CI 0.23-1.01。

临床怎么用

  • 对老年男性可考虑检测IL-6和hs-cTnT以辅助识别衰弱高风险个体。
  • CRP和NT-proBNP在衰弱风险分层中的价值有限,需结合其他指标。
  • 解读生物标志物与衰弱关联时需警惕生存偏倚的影响。

局限性

  • 仅纳入男性,结果外推至女性需谨慎。
  • CRP、IL-6、hs-cTnT和NT-proBNP均易受生存偏倚影响。
  • 随访期间死亡可能导致关联被低估或扭曲。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: cardiovascular disease (CVD) and chronic inflammation are implicated in the development of frailty. Longitudinal analyses of inflammatory markers, biomarkers of cardiac dysfunction and incidence of frailty are limited. METHODS: in the British Regional Heart Study, 1,225 robust or pre-frail men aged 71-92 years underwent a baseline examination, with questionnaire-based frailty assessment after 3 years. Frailty definitions were based on the Fried phenotype. Associations between incident frailty and biomarkers of cardiac dysfunction (high-sensitivity cardiac troponin T (hs-cTnT), N-terminal pro B-type natriuretic peptide (NT-proBNP)) and inflammation (C-reactive protein (CRP) and interleukin-6 (IL-6)) were examined, by tertile, with the lowest as reference. RESULTS: follow-up data were available for 981 men. Ninety one became frail. Adjusted for age, pre-frailty, prevalent and incident CVD, comorbidity, polypharmacy and socioeconomic status, IL-6 (third tertile OR 2.36, 95% CI 1.07-5.17) and hs-cTnT (third tertile OR 2.24, 95% CI 1.03-4.90) were associated with increased odds of frailty. CRP (third tertile OR 1.83, 95% CI 0.97-4.08) and NT-proBNP (second tertile OR 0.48, 95% CI 0.23-1.01) showed no significant association with incident frailty. The top tertiles of CRP, IL-6, hscTnT and NT-proBNP were strongly associated with mortality prior to follow-up. CONCLUSION: IL-6 is associated with incident frailty, supporting the prevailing argument that inflammation is involved in the pathogenesis of frailty. Cardiomyocyte injury may be associated with frailty risk. Associations between elevated CRP and frailty cannot be fully discounted; NT-proBNP may have a non-linear relationship with incident frailty. CRP, IL-6, hs-cTnT and NT-proBNP are vulnerable to survivorship bias.

来源:Age Ageing,查看原文。版权归原作者所有。

引用

  1. McKechnie DGJ, Papacosta AO, Lennon LT, et al. Associations between inflammation, cardiovascular biomarkers and incident frailty: the British Regional Heart Study. Age Ageing. 2021. PMID: 34254997. doi:10.1093/ageing/afab143

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。